Product Name: GLIVIN PM 1

Description: GLIVIN PM 1 is a pharmaceutical product in the form of a bilayered tablet, designed to provide a comprehensive approach to managing diabetes. Each tablet contains three active ingredients: Glimipride 1 mg, Metformin 500 mg (Sustained Release), and Pioglitazone 15 mg. This combination aims to address different aspects of diabetes management, offering a synergistic effect to help control blood sugar levels.

Ingredients:

1. Glimipride (1 mg): Glimipride is a sulfonylurea medication that stimulates the release of insulin from the pancreas, helping to lower blood sugar levels.
2. Metformin (500 mg SR – Sustained Release): Metformin is a commonly used oral antidiabetic medication that improves insulin sensitivity, reduces glucose production in the liver, and enhances glucose uptake by cells.
3. Pioglitazone (15 mg): Pioglitazone is a thiazolidinedione that helps improve insulin sensitivity in the body, allowing better utilization of insulin and, consequently, better blood sugar control.

Uses: GLIVIN PM 1 is prescribed for the management of Type 2 diabetes mellitus. The combination of these three active ingredients works together to regulate blood sugar levels effectively. The medication is intended to be part of a comprehensive diabetes management plan, which includes a proper diet, regular exercise, and other lifestyle modifications.

Side Effects: While GLIVIN PM 1 can be effective in managing diabetes, it may also be associated with certain side effects. It’s important to note that not everyone will experience these side effects, and their severity can vary. Common side effects may include:

1. Hypoglycemia (low blood sugar): This can cause symptoms such as dizziness, shakiness, sweating, and confusion. It is important to monitor blood sugar levels regularly.
2. Gastrointestinal issues: Some individuals may experience gastrointestinal discomfort, including nausea, vomiting, or diarrhea.
3. Edema: Pioglitazone, one of the components, may lead to fluid retention and peripheral edema in some individuals.
4. Weight gain: Thiazolidinediones like pioglitazone may be associated with weight gain in some patients.

It is crucial to consult with a healthcare professional before starting or making any changes to your medication regimen. They can provide personalized advice based on your medical history and help manage any potential side effects.